TC BIOPHARM (HOLDINGS) PLC
Maxim 1, 2 Parklands Way
Holytown, Motherwell ML1 4WR
Scotland, United Kingdom
August 9, 2024
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tyler Howes
Re: | TC BioPharm (Holdings) plc | |
Registration Statement on Form F-1 | ||
File No. 333-280659 |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), TC BioPharm (Holdings) plc (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on Monday, August 12, 2024, or as soon thereafter as possible.
Please notify Stephen Cohen of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 653-8166 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
Very truly yours, | ||
TC BIOPHARM (HOLDINGS) PLC | ||
By: | /s/ Bryan Kobel | |
Name: | Bryan Kobel | |
Title: | Chief Executive Officer |